Percutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis

M Agraharkar1, S Isaacson, D Mendelssohn

  • 1Division of Nephrology, Wellesley Hospital, Toronto, Ontario, Canada.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|April 1, 1995
PubMed

Insights

Internal jugular vein cannulation for hemodialysis access showed a low incidence of thrombosis. Percutaneous insertion appears less damaging than surgical methods for vascular access in end-stage renal failure patients.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Radiology

Background:

  • Vascular access is crucial for hemodialysis in end-stage renal failure.
  • Internal jugular vein cannulation is a common method for vascular access.
  • Assessing the risk of jugular vein thrombosis is important for patient safety.

Purpose of the Study:

  • To determine if internal jugular vein cannulation with soft silastic hemodialysis catheters causes jugular vein thrombosis.
  • To compare the incidence of thrombosis between percutaneous and surgical cannulation methods.

Main Methods:

  • Doppler ultrasound examinations were performed on 96 hemodialysis patients.
  • 144 catheter insertion episodes in 116 internal jugular veins were evaluated.
  • Thrombosis incidence was assessed for percutaneous and surgical Quinton PermCath insertions.

Main Results:

  • Two cases of internal jugular vein thrombosis were identified in 101 veins with percutaneous insertions.
  • Five cases of internal jugular vein thrombosis were found in 15 veins with surgical Quinton PermCath insertions.
  • The incidence of thrombosis was acceptably low for percutaneous cannulation.

Conclusions:

  • Percutaneous internal jugular vein cannulation for hemodialysis access results in a low incidence of jugular vein thrombosis.
  • Internal jugular vein is a suitable option for vascular access in end-stage renal failure.
  • Percutaneous cannulation is associated with less venous damage compared to surgical insertion.

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...